Treating children with tuberculosis: new weapons for an old enemy
Tommaso Matucci1, Luisa Galli1, Maurizio de Martino1
1Department of Health Sciences, Anna Meyer Children University Hospital, University of Florence , Florence , Italy.
Journal of Chemotherapy (Florence, Italy)
|May 7, 2019
Summary
Pediatric tuberculosis treatment differs significantly from adult care, necessitating tailored approaches for drug-susceptible, drug-resistant, and extrapulmonary tuberculosis in children to improve outcomes and safety.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) is a global health crisis impacting millions worldwide.
- Pediatric TB has been historically underserved, requiring specialized management strategies.
- Effective TB control necessitates addressing unique challenges in children.
Purpose of the Study:
- To highlight critical differences in TB treatment between children and adults.
- To analyze the impact of these differences on treatment outcomes, safety, and tolerability.
- To advocate for a more child-centered approach to pediatric TB management.
Main Methods:
- Comparative analysis of adult and pediatric TB treatment guidelines.
- Review of existing literature on pediatric TB pharmacotherapy and clinical management.
- Examination of safety and tolerability data for anti-TB drugs in pediatric populations.
Main Results:
- Pediatric TB treatment presents unique pharmacokinetic and pharmacodynamic challenges.
- Dosage adjustments and formulation development are crucial for effective pediatric TB therapy.
- Extrapulmonary and drug-resistant TB in children require distinct management protocols compared to adults.
Conclusions:
- Current TB treatment paradigms require significant adaptation for pediatric populations.
- A child-oriented approach is essential for optimizing treatment efficacy and minimizing adverse events in pediatric TB.
- Further research is needed to refine pediatric TB treatment strategies and improve global health outcomes.
Related Concept Videos
Pulmonary Tuberculosis I
883
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
883
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V
563
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
563
Pulmonary Tuberculosis III
1.0K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.0K
Pulmonary Tuberculosis IV
499
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
499
Drug Dosing: Infants and Children
266
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266


